WO2012128520A3 - 위식도 역류질환 치료용 액상 타입 조성물 - Google Patents

위식도 역류질환 치료용 액상 타입 조성물 Download PDF

Info

Publication number
WO2012128520A3
WO2012128520A3 PCT/KR2012/001949 KR2012001949W WO2012128520A3 WO 2012128520 A3 WO2012128520 A3 WO 2012128520A3 KR 2012001949 W KR2012001949 W KR 2012001949W WO 2012128520 A3 WO2012128520 A3 WO 2012128520A3
Authority
WO
WIPO (PCT)
Prior art keywords
liquid
reflux disease
gastroesophageal reflux
type composition
treating gastroesophageal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/001949
Other languages
English (en)
French (fr)
Other versions
WO2012128520A2 (ko
Inventor
김정훈
진성규
강경훈
김보견
이혜주
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dong A Pharmaceutical Co Ltd
Original Assignee
Dong A Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong A Pharmaceutical Co Ltd filed Critical Dong A Pharmaceutical Co Ltd
Publication of WO2012128520A2 publication Critical patent/WO2012128520A2/ko
Publication of WO2012128520A3 publication Critical patent/WO2012128520A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 신규한 위식도 역류질환 치료용 조성물에 관한 것이다. 본 발명에 따른 경구용 액상 조성물은, 저점도를 가지므로 환자의 복약편의성이 우수하고, 제조과정이 간단하며, 멸균조작이 용이한 장점을 가지며, 구조적으로 우수한 강도의 부유겔을 형성하여 위식도 역류질환 치료효과를 가진다.
PCT/KR2012/001949 2011-03-23 2012-03-19 위식도 역류질환 치료용 액상 타입 조성물 Ceased WO2012128520A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0025860 2011-03-23
KR1020110025860A KR20120108218A (ko) 2011-03-23 2011-03-23 위식도 역류질환 치료용 액상 타입 조성물

Publications (2)

Publication Number Publication Date
WO2012128520A2 WO2012128520A2 (ko) 2012-09-27
WO2012128520A3 true WO2012128520A3 (ko) 2012-11-15

Family

ID=46879876

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/001949 Ceased WO2012128520A2 (ko) 2011-03-23 2012-03-19 위식도 역류질환 치료용 액상 타입 조성물

Country Status (2)

Country Link
KR (1) KR20120108218A (ko)
WO (1) WO2012128520A2 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016048059A1 (ko) * 2014-09-24 2016-03-31 주식회사 태준제약 알긴산 또는 알긴산 염 및 감초 추출물을 포함하는 위장관 질환 치료용 조성물
KR102309593B1 (ko) * 2019-06-26 2021-10-07 재단법인 강릉과학산업진흥원 알긴산 나트륨을 주성분으로 함유한 위건강용 기능성 음료 조성물 및 이의 제조 방법
WO2024030933A1 (en) 2022-08-02 2024-02-08 Nutrition & Biosciences Usa 1, Llc Novel alginate and cellulose derivative based composition of the liquid anti-reflux formulation
JP2025525831A (ja) 2022-08-02 2025-08-07 ニュートリション アンド バイオサイエンシズ ユーエスエー １，リミティド ライアビリティ カンパニー アルギネートをベースとする放出調節組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
WO1996027368A1 (en) * 1995-03-03 1996-09-12 Reckitt & Colman Products Limited Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
US20050089577A1 (en) * 2002-03-04 2005-04-28 Hideakira Yokoyama Liquid matrix undergoing phase transfer in vivo and liquid oral preparations
US20080317855A1 (en) * 2005-07-28 2008-12-25 Reckitt Benckiser Healtcare (Uk) Limited, Particulate Compositions Comprising Alginate and/or Alginic Acid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
WO1996027368A1 (en) * 1995-03-03 1996-09-12 Reckitt & Colman Products Limited Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
US20050089577A1 (en) * 2002-03-04 2005-04-28 Hideakira Yokoyama Liquid matrix undergoing phase transfer in vivo and liquid oral preparations
US20080317855A1 (en) * 2005-07-28 2008-12-25 Reckitt Benckiser Healtcare (Uk) Limited, Particulate Compositions Comprising Alginate and/or Alginic Acid

Also Published As

Publication number Publication date
WO2012128520A2 (ko) 2012-09-27
KR20120108218A (ko) 2012-10-05

Similar Documents

Publication Publication Date Title
JO3199B1 (ar) مركبات 5- فلورو-1h- بيرازولوبيريدينات مستبدلة واستخدامها
EA201490546A1 (ru) Замещенные аннелированные пиримидины и их применение
MX2015009037A (es) Enjuague nasal con miel.
EA201291034A1 (ru) АПТАМЕРЫ К β-NGF И ИХ ПРИМЕНЕНИЕ ПРИ ЛЕЧЕНИИ B-NGF-ОПОСРЕДОВАННЫХ ЗАБОЛЕВАНИЙ И РАССТРОЙСТВ
EA201300669A1 (ru) Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение
PH12013501636A1 (en) Treatment of osteoarthritis and pain
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
WO2012062925A3 (en) Compounds and methods for treating pain
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
MY153062A (en) Methods of treating gastrointestinal disorders independent of the intake of food
EA201690520A1 (ru) Способ получения замещенных 5-фтор-1h-пиразолопиридинов
DK3045456T3 (da) Bicyklisk substituerede uraciler og anvendelse heraf
MX349254B (es) Compuestos para el tratamiento del sindrome metabolico.
CR20110552A (es) Tratamiento de transtornos resistentes a la insulina
WO2012128520A3 (ko) 위식도 역류질환 치료용 액상 타입 조성물
PH12014502071A1 (en) Beta-hydroxy-beta-methylbutyric acid for imrpoving glucose tolerance
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
EA200970816A1 (ru) Новая лекарственная форма
MX390695B (es) Composiciones farmaceuticas solidas antidiabeticas
UA114486C2 (uk) Застосування 4-амінопіридину у лікуванні пов'язаної з інсультом сенсорно-рухової недостатності
WO2012150607A3 (en) Oral liquid composition comprising divalproex sodium and process for preparing thereof
GEP20156373B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
MX351994B (es) Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico.
FR2974989B1 (fr) Lit, notamment lit medicalise pour le traitement de patients a domicile
HK1196602A1 (zh) 作為離子通道調節劑的稠合雜環化合物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12760933

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12760933

Country of ref document: EP

Kind code of ref document: A2